A detailed history of Intercontinental Wealth Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Intercontinental Wealth Advisors, LLC holds 20,529 shares of PFE stock, worth $575,838. This represents 0.18% of its overall portfolio holdings.

Number of Shares
20,529
Previous 21,365 3.91%
Holding current value
$575,838
Previous $871,000 13.55%
% of portfolio
0.18%
Previous 0.22%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 21, 2023

SELL
$36.12 - $41.79 $30,196 - $34,936
-836 Reduced 3.91%
20,529 $753,000
Q1 2023

May 03, 2023

SELL
$39.39 - $51.28 $47,858 - $62,305
-1,215 Reduced 5.38%
21,365 $871,000
Q4 2022

Feb 13, 2023

SELL
$41.75 - $54.5 $208,541 - $272,227
-4,995 Reduced 18.11%
22,580 $1.16 Million
Q3 2022

Nov 10, 2022

SELL
$43.76 - $53.42 $35,620 - $43,483
-814 Reduced 2.87%
27,575 $1.21 Million
Q2 2022

Aug 05, 2022

SELL
$46.53 - $55.17 $36,014 - $42,701
-774 Reduced 2.65%
28,389 $1.49 Million
Q1 2022

May 09, 2022

SELL
$45.75 - $56.69 $98,637 - $122,223
-2,156 Reduced 6.88%
29,163 $1.51 Million
Q4 2021

Feb 08, 2022

SELL
$41.32 - $61.25 $35,245 - $52,246
-853 Reduced 2.65%
31,319 $1.85 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $99,812 - $128,218
-2,543 Reduced 7.33%
32,172 $1.38 Million
Q2 2021

Aug 06, 2021

BUY
$35.91 - $40.68 $91,426 - $103,571
2,546 Added 7.91%
34,715 $1.36 Million
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $80,409 - $90,685
-2,401 Reduced 6.95%
32,169 $1.17 Million
Q4 2020

Feb 19, 2021

BUY
$33.47 - $42.56 $131,804 - $167,601
3,938 Added 12.86%
34,570 $1.27 Million
Q3 2020

Mar 10, 2021

SELL
$31.75 - $37.25 $214,852 - $252,070
-6,767 Reduced 18.09%
30,632 $1.12 Million
Q3 2020

Jan 19, 2021

BUY
$31.75 - $37.25 $71,024 - $83,328
2,237 Added 6.36%
37,399 $1.34 Million
Q2 2020

Mar 10, 2021

SELL
$30.12 - $36.54 $94,847 - $115,064
-3,149 Reduced 8.22%
35,162 $1.15 Million
Q2 2020

Jan 19, 2021

BUY
$30.12 - $36.54 $7,168 - $8,696
238 Added 0.63%
38,311 $1.66 Million
Q1 2020

Mar 10, 2021

SELL
$27.03 - $38.62 $94,767 - $135,401
-3,506 Reduced 8.43%
38,073 $1.24 Million
Q1 2020

Jan 19, 2021

BUY
$27.03 - $38.62 $724,809 - $1.04 Million
26,815 Added 181.62%
41,579 $1.77 Million
Q4 2019

Feb 07, 2020

SELL
$32.92 - $37.36 $745,144 - $845,643
-22,635 Reduced 60.52%
14,764 $564,000
Q3 2019

Oct 09, 2019

SELL
$32.49 - $42.13 $29,630 - $38,422
-912 Reduced 2.38%
37,399 $1.34 Million
Q2 2019

Aug 02, 2019

SELL
$36.98 - $41.52 $120,850 - $135,687
-3,268 Reduced 7.86%
38,311 $1.66 Million
Q1 2019

May 08, 2019

SELL
$37.5 - $41.2 $136,050 - $149,473
-3,628 Reduced 8.03%
41,579 $1.77 Million
Q4 2018

Jan 31, 2019

SELL
$38.47 - $43.86 $60,359 - $68,816
-1,569 Reduced 3.35%
45,207 $1.97 Million
Q3 2018

Oct 17, 2018

SELL
$34.47 - $41.81 $358,315 - $434,614
-10,395 Reduced 18.18%
46,776 $2.06 Million
Q2 2018

Jul 30, 2018

SELL
$32.98 - $35.16 $399,420 - $425,822
-12,111 Reduced 17.48%
57,171 $2.07 Million
Q1 2018

May 02, 2018

SELL
$31.91 - $37.02 $454,175 - $526,905
-14,233 Reduced 17.04%
69,282 $2.46 Million
Q4 2017

Feb 20, 2018

SELL
$33.26 - $35.29 $250,015 - $265,274
-7,517 Reduced 8.26%
83,515 $3.03 Million
Q3 2017

Nov 13, 2017

SELL
$31.0 - $34.15 $103,726 - $114,265
-3,346 Reduced 3.55%
91,032 $3.25 Million
Q2 2017

Aug 09, 2017

SELL
N/A
-14,569 Reduced 13.37%
94,378 $3.17 Million
Q1 2017

Mar 09, 2018

BUY
N/A
426 Added 0.39%
108,947 $3.73 Million
Q4 2016

Mar 09, 2018

BUY
N/A
5,168 Added 5.0%
108,521 $3.53 Million
Q3 2016

Mar 12, 2018

SELL
N/A
-4,168 Reduced 3.88%
103,353 $3.5 Million
Q2 2016

Mar 09, 2018

SELL
N/A
-5,898 Reduced 5.2%
107,521 $3.79 Million
Q1 2016

Mar 09, 2018

SELL
N/A
-15,306 Reduced 11.89%
113,419 $3.36 Million
Q4 2015

Mar 09, 2018

BUY
N/A
128,725
128,725 $4.16 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Intercontinental Wealth Advisors, LLC Portfolio

Follow Intercontinental Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intercontinental Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intercontinental Wealth Advisors, LLC with notifications on news.